Abstract: Due to the wide dynamic range in real low-light scenes, there will be large differences in the degree of contrast degradation and detail blurring of captured images, making it difficult for ...

A month has gone by since the last earnings report for Recursion Pharmaceuticals (RXRX). Shares have lost about 16.5% in that time frame, underperforming the S&P 500. Will the recent negative trend ...

Abstract: In the automation era, DC motors are widely utilized across various industries due to their adaptability and efficiency. In the downside of reality, accurately modelling and controlling ...

Great. Thanks, everyone, for joining. My name is Scott Schoenhaus. I am the health care tech equity analyst here at KeyBanc. We're a pleasure to have Ben Taylor, CFO of Recursion for a fireside chat.

Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) is one of the stocks Jim Cramer answered questions about. When a caller mentioned that Cathie Wood invested in the stock, Cramer remarked, “That’s, it’s a ...